Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 16 entries
Sorted by: Best Match Show Resources per page
The Hepatocyte nuclear factor-1 alpha ( HNF1A) gene is associated with fatness and loin muscle area in the pig.

Animal : an international journal of animal bioscience

Fan B, Du ZQ, Rothschild MF.
PMID: 22445113
Animal. 2010 Oct;4(10):1619-27. doi: 10.1017/S175173111000087X.

The significance of hepatocyte nuclear factors (HNFs) in β-cell development and function has been generally recognized in humans, as evidenced by their associations with cases of maturity onset diabetes of the young (MODY). Common Hepatocyte nuclear factor-1 alpha (HNF1A),...

The Hepatocyte nuclear factor-1 alpha ( HNF1A) gene is associated with fatness and loin muscle area in the pig.

Animal : an international journal of animal bioscience

Fan B, Du ZQ, Rothschild MF.
PMID: 22445113
Animal. 2010 Oct;4(10):1619-27. doi: 10.1017/S175173111000087X.

The significance of hepatocyte nuclear factors (HNFs) in β-cell development and function has been generally recognized in humans, as evidenced by their associations with cases of maturity onset diabetes of the young (MODY). Common Hepatocyte nuclear factor-1 alpha (HNF1A),...

Maturity-onset diabetes of the young type 5, presenting as diabetic ketoacidosis with alkalemia: A report of a case.

Journal of diabetes investigation

Hayakawa-Iwamoto A, Aotani D, Shimizu Y, Kakoi S, Hasegawa C, Itoh S, Fujii A, Takeda K, Yagi T, Koyama H, Imaeda K, Nozu K, Nagano C, Kataoka H, Tanaka T.
PMID: 34931465
J Diabetes Investig. 2021 Dec 20; doi: 10.1111/jdi.13737. Epub 2021 Dec 20.

A 34-year-old man visited our Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan, because of dry mouth and weight loss. His plasma glucose level was 32.8 mmol/L and serum levels of ketone...

Maturity-onset diabetes of the young (MODY) type 5, presenting as diabetic ketoacidosis with alkalemia - A report of a case.

Journal of diabetes investigation

Hayakawa-Iwamoto A, Aotani D, Shimizu Y, Kakoi S, Hasegawa C, Itoh S, Fujii A, Takeda K, Yagi T, Koyama H, Imaeda K, Nozu K, Nagano C, Kataoka H, Tanaka T.
PMID: 34931465
J Diabetes Investig. 2021 Dec 20; doi: 10.1111/jdi.13737. Epub 2021 Dec 20.

A 34-year-old man visited our hospital because of dry mouth and weight loss. His plasma glucose level was 32.8 mmol/L and serum levels of ketone bodies were increased, but with metabolic alkalemia. He was also suffering from renal tubular...

Hepatocyte Nuclear Factor 1 Beta Mutation-associated Newborn Onset of Glomerulocystic Kidney Disease: A Case Presentation.

Medeniyet medical journal

Goknar N, Ekici Avci M, Uckardes D, Kelesoglu E, Tekkus Ermis K, Candan C.
PMID: 34939403
Medeni Med J. 2021 Dec 19;36(4):352-355. doi: 10.4274/MMJ.galenos.2021.02686.

Mutations in hepatocyte nuclear factor-1 beta (

Comprehensive quantitative analysis of alternative splicing variants reveals the HNF1B mRNA splicing pattern in various tumour and non-tumour tissues.

Scientific reports

Hojny J, Michalkova R, Krkavcova E, Bui QH, Bartu M, Nemejcova K, Kalousova M, Kleiblova P, Dundr P, Struzinska I.
PMID: 34997048
Sci Rep. 2022 Jan 07;12(1):199. doi: 10.1038/s41598-021-03989-z.

Hepatocyte nuclear factor-1-beta (HNF1B) is a transcription factor and putative biomarker of solid tumours. Recently, we have revealed a variety of HNF1B mRNA alternative splicing variants (ASVs) with unknown, but potentially regulatory, functions. The aim of our work was...

Comprehensive quantitative analysis of alternative splicing variants reveals the HNF1B mRNA splicing pattern in various tumour and non-tumour tissues.

Scientific reports

Hojny J, Michalkova R, Krkavcova E, Bui QH, Bartu M, Nemejcova K, Kalousova M, Kleiblova P, Dundr P, Struzinska I.
PMID: 34997048
Sci Rep. 2022 Jan 07;12(1):199. doi: 10.1038/s41598-021-03989-z.

Hepatocyte nuclear factor-1-beta (HNF1B) is a transcription factor and putative biomarker of solid tumours. Recently, we have revealed a variety of HNF1B mRNA alternative splicing variants (ASVs) with unknown, but potentially regulatory, functions. The aim of our work was...

Molecular and biochemical analysis of the MODY syndromes.

Pediatric diabetes

Winter WE.
PMID: 15016234
Pediatr Diabetes. 2000 Jun;1(2):88-117. doi: 10.1034/j.1399-5448.2000.010206.x.

Maturity onset diabetes of the young (MODY) is characterized by youth-onset diabetes that is inherited in an autosomal dominant (monogenic) pattern. Classic MODY accounts for less than 5% of cases of childhood diabetes in Caucasians, presents prior to age...

Asymptomatic proteinuria, renal cysts and dorsal pancreas agenesis.

Clinical kidney journal

Lim CC, Lai AH, Choo JC.
PMID: 25852921
Clin Kidney J. 2014 Aug;7(4):411-2. doi: 10.1093/ckj/sfu066. Epub 2014 Jun 23.

No abstract available.

A novel splice-site mutation of the HNF1B gene in a family with maturity onset diabetes of the young type 5 (MODY5).

Endocrinology, diabetes & metabolism case reports

Fujita Y, Tanaka D, Tatsuoka H, Matsubara M, Hyo T, Hamamoto Y, Komiya T, Inagaki N, Seino Y, Yamazaki Y.
PMID: 33434175
Endocrinol Diabetes Metab Case Rep. 2020 Sep 23;2020. doi: 10.1530/EDM-20-0092. Epub 2020 Sep 23.

SUMMARY: Maturity-onset diabetes of the young (MODY) is a form of monogenic diabetes mellitus characterised by early onset and dominant inheritance. Delayed diagnosis or misdiagnosis as type 1 or type 2 diabetes mellitus is common. Definitive genetic diagnosis is...

Hepatocyte Nuclear Factor 1 Beta Mutation-associated Newborn Onset of Glomerulocystic Kidney Disease: A Case Presentation.

Medeniyet medical journal

Goknar N, Ekici Avci M, Uckardes D, Kelesoglu E, Tekkus Ermis K, Candan C.
PMID: 34939403
Medeni Med J. 2021 Dec 19;36(4):352-355. doi: 10.4274/MMJ.galenos.2021.02686.

Mutations in hepatocyte nuclear factor-1 beta (

Primary Clear Cell Carcinoma of the Pancreas: A Systematic Review.

Cureus

Tannous T, Perez Rodriguez AL, Mak AW, Tannous K, Keating M.
PMID: 34150416
Cureus. 2021 Jun 15;13(6):e15668. doi: 10.7759/cureus.15668.

Over the years, the world has witnessed many advances in diagnosing and treating multiple types of cancers. These breakthroughs have revolutionized the understanding of the molecular drive behind these neoplasms, leading to tangible therapeutic evolution and promising prognostic implications....

Showing 1 to 12 of 16 entries